It was recently reported that the sera of patients with relapsed/progressed MM reacted with antibodies to CAI, II, IX and XII and patients with elevated CA autoantibody titers had a significant survival benefit over those who did not (27). The gene discussed is CA1; the disease is Miyoshi myopathy.